Hanson Kristopher 4

What Happened
Kristopher Hanson, General Counsel of MapLight Therapeutics (MPLT), sold a total of 13,917 shares on May 11, 2026 in a series of open-market transactions. The four reported sales were: 284 shares at a weighted avg $27.61 ($7,841), 846 shares at $28.70 ($24,280), 6,979 shares at $30.04 ($209,649), and 5,808 shares at $30.56 ($177,492), for aggregate proceeds of approximately $419,262. These were sales (S) — routine dispositions rather than purchases.

Key Details

• Transaction date: May 11, 2026; filing date (Form 4 accession): May 11, 2026 (appears timely).
• Total shares sold: 13,917; total proceeds: ~$419,262.
• Reported prices are weighted averages and were sold in multiple executions; per-footnote price ranges: 27.26–28.08, 28.30–29.183, 29.305–30.2965, and 30.305–30.90 (see F2–F5).
• Footnote F1 indicates at least one of the transactions was executed pursuant to a Rule 10b5‑1 trading plan adopted by the reporting person on December 29, 2025.
• Shares owned after the transaction are not specified in the material provided here.

Context
These were open-market sales by a company insider. Sales executed under a pre-established 10b5‑1 plan are typically scheduled trades and do not, by themselves, indicate a change in an insider’s view of the company. This summary is factual only and does not speculate on motivations. If you want, I can pull the full Form 4 text or confirm post-transaction holdings from the filing.